Literature DB >> 9298817

E280A PS-1 mutation causes Alzheimer's disease but age of onset is not modified by ApoE alleles.

C L Lendon1, A Martinez, I M Behrens, K S Kosik, L Madrigal, J Norton, R Neuman, A Myers, F Busfield, M Wragg, M Arcos, J C Arango Viana, J Ossa, A Ruiz, A M Goate, F Lopera.   

Abstract

A single base substitution of a glutamic acid to an alanine codon 280 was found in the presenilin-1 (PS-1) gene on chromosome 14 in affected individuals in each of seven Colombian early-onset Alzheimer's disease (AD) kindreds. The mutation segregated with disease in kindreds tested. In the largest kindred (C2), the maximum two-point lod score between the mutation and AD was Z = 8.14 at theta = 0. The presence of a single mutation and the common geographic origin, with all families from the state of Antioquia, suggest a founder effect in this population. This finding is supported by the observation of a rare haplotype inherited with AD in all kindreds. These kindreds form the largest collection of AD cases with the same PS-1 mutation and the same educational, environmental, and ethnic background in which to study the phenotypic effect of putative risk factors, such as the epsilon4 allele of apolipoprotein E (ApoE) or head trauma. Of the few AD cases having a history of head trauma, the age of onset was not lowered. No effect of ApoE genotype on the age of onset was detected. Previous investigations of the effect of ApoE genotype on the age of onset were confounded by small patient numbers, familial clustering of ApoE genotypes, and combining data from unrelated families with different mutations.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9298817     DOI: 10.1002/(SICI)1098-1004(1997)10:3<186::AID-HUMU2>3.0.CO;2-H

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  22 in total

1.  Hippocampal hyperactivation in presymptomatic familial Alzheimer's disease.

Authors:  Yakeel T Quiroz; Andrew E Budson; Kim Celone; Adriana Ruiz; Randall Newmark; Gabriel Castrillón; Francisco Lopera; Chantal E Stern
Journal:  Ann Neurol       Date:  2010-12       Impact factor: 10.422

2.  Plasma neurofilament light chain in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional and longitudinal cohort study.

Authors:  Yakeel T Quiroz; Henrik Zetterberg; Eric M Reiman; Yinghua Chen; Yi Su; Joshua T Fox-Fuller; Gloria Garcia; Andres Villegas; Diego Sepulveda-Falla; Marina Villada; Joseph F Arboleda-Velasquez; Edmarie Guzmán-Vélez; Clara Vila-Castelar; Brian A Gordon; Stephanie A Schultz; Hillary D Protas; Valentina Ghisays; Margarita Giraldo; Victoria Tirado; Ana Baena; Claudia Munoz; Silvia Rios-Romenets; Pierre N Tariot; Kaj Blennow; Francisco Lopera
Journal:  Lancet Neurol       Date:  2020-05-26       Impact factor: 44.182

3.  Brain Imaging and Blood Biomarker Abnormalities in Children With Autosomal Dominant Alzheimer Disease: A Cross-Sectional Study.

Authors:  Yakeel T Quiroz; Aaron P Schultz; Kewei Chen; Hillary D Protas; Michael Brickhouse; Adam S Fleisher; Jessica B Langbaum; Pradeep Thiyyagura; Anne M Fagan; Aarti R Shah; Martha Muniz; Joseph F Arboleda-Velasquez; Claudia Munoz; Gloria Garcia; Natalia Acosta-Baena; Margarita Giraldo; Victoria Tirado; Dora L Ramírez; Pierre N Tariot; Bradford C Dickerson; Reisa A Sperling; Francisco Lopera; Eric M Reiman
Journal:  JAMA Neurol       Date:  2015-08       Impact factor: 18.302

4.  Cognitive Decline in a Colombian Kindred With Autosomal Dominant Alzheimer Disease: A Retrospective Cohort Study.

Authors:  Daniel C Aguirre-Acevedo; Francisco Lopera; Eliana Henao; Victoria Tirado; Claudia Muñoz; Margarita Giraldo; Shrikant I Bangdiwala; Eric M Reiman; Pierre N Tariot; Jessica B Langbaum; Yakeel T Quiroz; Fabian Jaimes
Journal:  JAMA Neurol       Date:  2016-04       Impact factor: 18.302

5.  Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum.

Authors:  D Campion; C Dumanchin; D Hannequin; B Dubois; S Belliard; M Puel; C Thomas-Anterion; A Michon; C Martin; F Charbonnier; G Raux; A Camuzat; C Penet; V Mesnage; M Martinez; F Clerget-Darpoux; A Brice; T Frebourg
Journal:  Am J Hum Genet       Date:  1999-09       Impact factor: 11.025

Review 6.  Alzheimer's Prevention Initiative: a plan to accelerate the evaluation of presymptomatic treatments.

Authors:  Eric M Reiman; Jessica B S Langbaum; Adam S Fleisher; Richard J Caselli; Kewei Chen; Napatkamon Ayutyanont; Yakeel T Quiroz; Kenneth S Kosik; Francisco Lopera; Pierre N Tariot
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

7.  Successful Scene Encoding in Presymptomatic Early-Onset Alzheimer's Disease.

Authors:  Yakeel T Quiroz; Kim Celone Willment; Gabriel Castrillon; Martha Muniz; Francisco Lopera; Andrew Budson; Chantal E Stern
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

8.  The allelic modulation of apolipoprotein E expression by oestrogen: potential relevance for Alzheimer's disease.

Authors:  J-C Lambert; N Coyle; C Lendon
Journal:  J Med Genet       Date:  2004-02       Impact factor: 6.318

9.  Clinical and molecular studies reveal a PSEN1 mutation (L153V) in a Peruvian family with early-onset Alzheimer's disease.

Authors:  Mario R Cornejo-Olivas; Chang-En Yu; Pilar Mazzetti; Ignacio F Mata; Maria Meza; Saul Lindo-Samanamud; James B Leverenz; Thomas D Bird
Journal:  Neurosci Lett       Date:  2014-02-02       Impact factor: 3.046

10.  Cortical atrophy in presymptomatic Alzheimer's disease presenilin 1 mutation carriers.

Authors:  Yakeel T Quiroz; Chantal E Stern; Eric M Reiman; Michael Brickhouse; Adriana Ruiz; Reisa A Sperling; Francisco Lopera; Bradford C Dickerson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-11-07       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.